Reply to ‘Comment on “Validation of a Contemporary Prostate Cancer Grading System Using Prostate Cancer Death as Outcome”’

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2016.347
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2012English

Prostate Cancer, Prostate Cancer Death, and Death From Other Causes, Among Men With Metabolic Aberrations

Epidemiology
Epidemiology
2014English

Independent Surgical Validation of the New Prostate Cancer Grade-Grouping System

BJU International
Urology
2016English

Therapy for Prostate Cancer: The Authors Reply

Health Affairs
MedicineHealth Policy
2012English

Is a Negative Prostate Biopsy a Risk Factor for a Prostate Cancer Related Death?

The Lancet Oncology
Oncology
2017English

The Drama of Prostate Cancer Diagnostics – Authors' Reply

The Lancet Oncology
Oncology
2017English

Predicting Clinical Outcome of Therapy-Resistant Prostate Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

On the Trail of Cell Death Pathways in Prostate Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2004English

The Contemporary Concept of Significant Versus Insignificant Prostate Cancer

European Urology
Urology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy